Skip to main navigation
logo
  • Overview
  • News & Events
    • Press Releases
    • Calendar of Events
    • Presentations
  • Financial Info
    • SEC Filings
    • Supplemental Financial Information
  • Corporate Governance
    • Documents & Charters
    • Leadership
    • Board of Directors
    • Committee Composition
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Investor Resources
    • FAQ
    • Information Requests
    • IR Contact

EXINI Diagnostics AB, a Lantheus Company, Receives CE Mark Clearance for aPROMISE in Europe

  • Read more about EXINI Diagnostics AB, a Lantheus Company, Receives CE Mark Clearance for aPROMISE in Europe

Lantheus Grants Allegheny Health Network Exclusive Rights for the Use of its Microbubbles in Combination with Ultrasound Assisted Gene Therapy for the Development of a Proposed Treatment for Xerostomia

  • Read more about Lantheus Grants Allegheny Health Network Exclusive Rights for the Use of its Microbubbles in Combination with Ultrasound Assisted Gene Therapy for the Development of a Proposed Treatment for Xerostomia

Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time

  • Read more about Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time

Lantheus Expands R&D Leadership Team with Key New Hires

  • Read more about Lantheus Expands R&D Leadership Team with Key New Hires

Lantheus Announces Retirement of Michael P. Duffy, Senior Vice President and General Counsel

  • Read more about Lantheus Announces Retirement of Michael P. Duffy, Senior Vice President and General Counsel

Lantheus Acquires Rights to Innovative Imaging Biomarker Targeting Fibroblast Activation Protein (FAP) from Noria

  • Read more about Lantheus Acquires Rights to Innovative Imaging Biomarker Targeting Fibroblast Activation Protein (FAP) from Noria

Lantheus Announces Presentation Featuring AZEDRA® (iobenguane I 131) at ENDO 2021

  • Read more about Lantheus Announces Presentation Featuring AZEDRA® (iobenguane I 131) at ENDO 2021

Lantheus Announces Publication of PyL™ (18F-DCFPyL) Results from Pivotal Studies

  • Read more about Lantheus Announces Publication of PyL™ (18F-DCFPyL) Results from Pivotal Studies

Lantheus Reports Fourth Quarter and Full Year 2020 Financial Results

  • Read more about Lantheus Reports Fourth Quarter and Full Year 2020 Financial Results

Lantheus Holdings to Present at the 10th Annual SVB Leerink Global Healthcare Conference

  • Read more about Lantheus Holdings to Present at the 10th Annual SVB Leerink Global Healthcare Conference

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Current page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Site - Shareholder Services

Print Page
RSS Feeds
Email Alerts
  • Copyright © 2025 Lantheus Holdings, Inc. All rights reserved.